Abstract

Feline Transdermal Formulation Considerations

Author(s): Forsythe Lauren Eichstadt

Issue: Nov/Dec 2017 - Volume 21, Number 6

Page(s): 446-452

Download in electronic PDF format for $75
  • Feline Transdermal Formulation Considerations Page 1
  • Feline Transdermal Formulation Considerations Page 2
  • Feline Transdermal Formulation Considerations Page 3
  • Feline Transdermal Formulation Considerations Page 4
  • Feline Transdermal Formulation Considerations Page 5
  • Feline Transdermal Formulation Considerations Page 6
  • Feline Transdermal Formulation Considerations Page 7

Abstract

Transdermal delivery of drugs is comparatively new in feline patients. However, transdermal formulations can be a desirable option for treating feline patients that are not willing participants to medication administration. However, achieving drug penetration across the skin is not always easy, and there are a wide variety of variables that can further affect penetration. This, coupled with a lack of studies, make transdermal administration an unknown with regards to efficacy and safety for many drugs. This article focuses on drugs that are administered transdermally with the intent of producing systemic effects.

Related Keywords

  • cats
  • veterinary compounding
  • transdermal delivery
  • drug penetration
  • drug safety
  • topical preparations
  • drug absorption
  • skin structure
  • dermal penetration enhancer
  • stratum corneum thickness

Related Categories

  • EXCIPIENTS
  • STABILITIES, COMPATIBILITIES
  • VETERINARY
  • DOSAGE FORMS/DRUG CARRIERS

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Mar/Apr 2003
Pg. 106-113
Veterinary Transdermal Medications: A to Z
Author(s): Davidson Gigi S
Nov/Dec 2017
Pg. 446-452
Feline Transdermal Formulation Considerations
Author(s): Forsythe Lauren Eichstadt
May/Jun 2016
Pg. 250-256
Effect of Penetration Enhancers on the Percutaneous Delivery of Pain Management Actives
Author(s): Trimble John, Light Bob
Nov/Dec 2017
Pg. 530-535
Effect of Penetration Enhancers on the Percuaneous Delivery of Hormone Replacement Actives
Author(s): Trimble John O, Light Bob
Nov/Dec 2018
Pg. 498-503
Gabapentin in Elastic Liposomes: Preparation, Characterization, Drug Release, and Penetration Through Porcine Skin
Author(s): Le Uyen Minh, Baltzley Sarah, AlGhananeem Abeer
Jul/Aug 2011
Pg. 308-315
Transdermals: The Skin as Part of a Drug Delivery System
Author(s): Allen Loyd V Jr
May/Jun 2013
Pg. 247-253
Effect of Formulation pH on Transdermal Penetration of Antiemetics Formulated in Poloxamer Lecithin Organogel
Author(s): Woodall Rachel, Arnold John J, McKay Doug, Abill C Scott
Sep/Oct 2022
Pg. 400-408
Basics of Compounding: Compounding with Microneedle Arrays, Part 1: Introduction and Overview
Author(s): Allen Loyd V Jr
Sep/Oct 2014
Pg. 366-369
To Compound or Not to Compound: A Veterinary Transdermal Discussion
Author(s): Eichstadt Lauren R, Davidson Gigi S
Nov/Dec 2014
Pg. 512-515
In Vitro Skin Penetration and Skin Content of Progesterone from Various Topical Formulations
Author(s): Heustess Allie, Asbill Scott, Eagerton David, Arnold John
Nov/Dec 2009
Pg. 569-571
The Release and Transdermal Penetration of Baclofen Formulated in a Poloxamer Lecithin Organogel
Author(s): Arnold John J, Asbill Scott
Jan/Feb 2020
Pg. 30-36
Quality Control: Personal Protective Equipment for Use When Handling Hazardous Drugs
Author(s): Dillon L R
Nov/Dec 2014
Pg. 504-511
Skin Penetration and Antinociception of Topical Gabapentin Formulations
Author(s): Bryson Evan, Asbill Scott, Sweitzer Sarah
Sep/Oct 2013
Pg. 370-374
Chemical Penetration Enhancers
Author(s): Newton Stephen J
Jul/Aug 2016
Pg. 271-274
Compounding Transdermal Medication for Feline Patients
Author(s): Eichstadt Lauren R
Nov/Dec 2020
Pg. 446-448
NASEM Report on Compounded Topical Pain Creams
Author(s): Allen Loyd V Jr
Nov/Dec 2020
Pg. 501-508
Drug-release Assessment of Compounded Topical Nifedipine and Diltiazem in Commonly Used Bases for Wound Healing
Author(s): Teimouri Arezou, Yeung Pollen, Agu Remigius U
Sep/Oct 2022
Pg. 385-395
Compounding with Biotechnology Products, Part 1: General Considerations
Author(s): Allen Loyd V Jr
Nov/Dec 1999
Pg. 496-500
Enhancement of Skin Penetration of Nonsteroidal Anti-Inflammatory Drugs from Extemporaneously Compounded Topical-Gel Formulations
Author(s): Goodwin Donald A, Fuhram L Clifton
Jul/Aug 2004
Pg. 269-274
Current Topical Treatments in Wound Healing - Part 1
Author(s): Helmke Christopher D